OPKO Health to acquire Cytochroma
Cytochroma has entered into a definitive agreement to be acquired by OPKO Health, Inc. Through the transaction, OPKO will acquire worldwide rights to Cytochroma’s two lead product candidates:...
View ArticlePEI’s BioVectra bought by Questcor Pharmaceuticals
BioVectra, a supplier to international pharmaceutical companies, has agreed to a purchase by California-based Questcor Pharmaceuticals for an upfront payment of $50 million. The value of the deal could...
View ArticleInflamax Research launches its Mobile Environmental Exposure Chamber™
Inflamax Research has developed and validated a unique Mobile Environmental Exposure Chamber™ System, which enables the pharmaceutical industry to perform single or multi-centre environmental exposure...
View Article$67 million grant to support operation of national synchrotron facility
Canada’s national synchrotron, the Canadian Light Source (CLS) at the University of Saskatchewan, has been awarded up to $67 million over five years toward operating and maintenance costs through the...
View ArticleBIO International Convention to highlight hot topics in the biotech industry
The 2013 BIO International Convention will feature a program of more than 800 speakers in over 125 sessions across 15 topic areas addressing the latest business opportunities and challenges as well as...
View ArticleVIDEO: Genomics: The Power and The Promise keynote speaker Eric Lander
One of the great scientific ‘thought leaders of our time,’ Eric Lander looks back at the last 10 years of genomic advancements, and where this revolutionary science is headed as the keynote speaker at...
View ArticlePEI biotech company receives $1.5 million in private financing
Neurodyn Inc., a biotechnology company based in Charlottetown, PEI, announces it has raised $1,500,000 in private financing. The investors included the Regis Duffy BioScience Fund Inc., based in...
View ArticleMethylGene announces Mark J. Gergen as executive vice president and COO
MethylGene Inc. today announced that Mark J. Gergen has been appointed to the position of Executive Vice President and Chief Operations Officer, effective immediately. In this new role, Gergen will...
View ArticleClik here to view.
New personalized medicine public-private partnership for cancer research
L to R: Dr. Gerald Batist, professor of Oncology at McGill University and co-director of the Québec Clinical Research Organization in Cancer (Q-CROC); Élaine Zakaïb, Minister for Industrial Policy and...
View ArticleBioactive peptides from flax to be tested for use in pharmaceuticals and...
Bioactive peptides from flax will be recovered and tested for safety for use in pharmaceuticals and neutraceuticals. Flax and flaxseed oil are popular health foods because they are sources of omega-3...
View ArticleClik here to view.
Sanofi Pasteur: A Canadian success story
As the biotech industry grows slowly but steadily in Canada, a select few companies have become a global success story. Sanofi Pasteur Canada is one such rarity. Part of health-care giant Sanofi,...
View ArticleCQDM and the Massachusetts Life Sciences Center launch new international...
The Québec Consortium for Drug Discovery (CQDM) is joining the Massachusetts Life Sciences Center (MLSC) in a new initiative to create a new International Collaborative Industry Program (ICIP)....
View ArticleClik here to view.
Cell therapy and regenerative medicine centres in Canada and UK to work together
The Centre for Commercialization of Regenerative Medicine (CCRM) and the Cell Therapy Catapult , government-funded translation centres in Canada and the UK , have signed a collaboration agreement that...
View ArticleClik here to view.
Inflamax Research launches its Mobile Environmental Exposure Chamber™
Inflamax Research has developed and validated a unique Mobile Environmental Exposure Chamber™ System, which enables the pharmaceutical industry to perform single or multi-centre environmental exposure...
View ArticleClik here to view.
$18.4 million investment to improve clinical research in cancer
Innovative approach to cancer research holds the promise of introducing novel therapies and more effective treatment for patients The Québec – Clinical Research Organization in Cancer (Q-CROC) was...
View ArticleClik here to view.
MethylGene announces Mark J. Gergen as executive vice president and COO
MethylGene Inc. today announced that Mark J. Gergen has been appointed to the position of Executive Vice President and Chief Operations Officer, effective immediately. In this new role, Gergen will...
View ArticleClik here to view.
$18.4 million investment to improve clinical research in cancer
Innovative approach to cancer research holds the promise of introducing novel therapies and more effective treatment for patients The Québec – Clinical Research Organization in Cancer (Q-CROC) was...
View ArticleClik here to view.
Clinical trials initiated for a new molecule jointly identified by IRIC and...
The Université de Montréal (UdeM) has announced that it’s starting clinical trials for a new molecule that was jointly discovered by the Institute of Research in Immunology and Cancer (IRIC), and...
View ArticleClik here to view.
Valeant Pharmaceuticals expands into Middle East and North Africa, acquires...
Laval, QC — Valeant Pharmaceuticals International, Inc. has reached an agreement to buy Egyptian drug maker Amoun Pharmaceutical for approximately US$800 million, plus contingent payments. Please Login...
View ArticleClik here to view.
Life Sciences Ontario’s Annual Life Sciences Policy Forum – EP. 1.5
On this week’s show, Biotechnology Focus Editor-in-chief Terri Pavelic goes one-on-one with Life Sciences Ontario chair John Kelly to discuss the upcoming LSO Annual Life Sciences Policy Forum: Towards...
View Article
